News & Updates

Risk of death 54 percent lower with remdesivir added for hospitalized COVID-19 patients on O₂ support
Risk of death 54 percent lower with remdesivir added for hospitalized COVID-19 patients on O₂ support
01 Jul 2024
SABA may be overprescribed for asthma in SG
SABA may be overprescribed for asthma in SG
27 Jun 2024
Off-label targeted drugs improve survival in CTEPH
Off-label targeted drugs improve survival in CTEPH
26 Jun 2024

Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.

Off-label targeted drugs improve survival in CTEPH
26 Jun 2024